New device aims to zap small lung tumors before surgery

NCT ID NCT07122258

Recruiting now Disease control Sponsor: Tau Medical Australia Pty Ltd Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study is testing the safety of a new device called CAROL for treating small lung tumors (≤2 cm) in people with non-small cell lung cancer. Seven participants will receive a single treatment with the device, followed by surgical removal of the tumor. The main goal is to see if the device is safe and to check for any side effects within the first month.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CAROL device (a conformable electrode for tumor ablation)
What this could lead to: If successful, this could lead to a less invasive treatment option for small lung tumors, potentially reducing the need for more extensive surgery.
What could go wrong: This is a very early, small safety study with only 7 participants. The device may not work as intended, and risks include side effects from the procedure. It is not yet proven to be effective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NSCLC (NON-SMALL CELL LUNG CANCER)

Contacts and locations

Locations

Royal Melbourne Hospital
RECRUITING

Melbourne, Victoria, 3050, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.